On September 9, 2019 Avelas Biosciences, Inc., a clinical-stage oncology company developing AVB-620 for real-time cancer detection, reported that it will be presenting at two upcoming conferences in the month of September (Press release, Athenex, SEP 9, 2019, View Source [SID1234539369]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Plastic Surgery The Meeting, September 19-23, 2019

Dr. Steven Chen, Avelas’ Chief Medical Officer, will be participating in a "Hot Topics" session at the 88th Annual Plastic Surgery The Meeting on Thursday, September 19, 2019, in San Diego, CA. The session will discuss the latest cutting-edge research and applied technology of interest to plastic surgeons.

The MedTech Conference, September 23-25, 2019

On Tuesday, September 24, 2019, Jay Lichter, Avelas’ Chief Executive Officer, will be participating in the MedTech Innovator Showcase (Oncology) panel session at The MedTech Conference in Boston, MA. The session will be held in Hall B, 500 Aisle from 10:30-11:00am.

As part of its participation in the MedTech Showcase program, Avelas has also submitted a pitch video to the MedTech Innovator Best Video Competition. Avelas’ video can be viewed below.

Throughout the three-day conference, Avelas will be available for partnering. Interested parties may reach out to the company through The MedTech Connect networking platform or directly contact Will Stratton, Avelas’ Head of Business Development ([email protected]).